Archive - March 2021
EMA review confirms AZ/Oxford’s COVID-19 vaccine is safe and effective
Havas Lynx and Syneos take home most agency Golds at PM Society awards
EU authorisation for XPhyto’s rapid COVID-19 PCR test
ICR’s ‘resistance-busting’ drug advances into Phase I trial
NICE approves Lynparza plus Avastin via Cancer Drugs Fund
UK and EU regulators reaffirm the safety of AZ/Oxford Uni’s COVID-19 vaccine
Q&A: Avril Lee
Your Toothbrush Near the Toilet? Let’s Rethink Proximity, Please